BOEUF (Bonesupport Holding AB) Days Sales Outstanding: 55.54 (As of Jun. 2026) — 10% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOEUF Bonesupport Holding AB BOEUF
79 GF Score
Price $24.43
GF Value $44.52
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Days Sales Outstanding?

Bonesupport Holding AB BOEUF 79 Days Sales Outstanding is 55.54 as of Jun. 2026, which is 10% below its 10-year median of 61.49. GuruFocus rates BOEUF with a GF Score™ of 79/100 and a GF Value™ of $44.52 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Bonesupport Holding AB ranks better than 59.31% on this metric.

Bonesupport Holding AB's average Accounts Receivable for the three months ended in Jun. 2026 was $23.1 Mil. Bonesupport Holding AB's Revenue for the three months ended in Jun. 2026 was $38.0 Mil. Hence, Bonesupport Holding AB's Days Sales Outstanding for the three months ended in Jun. 2026 was 55.54.

The historical rank and industry rank for Bonesupport Holding AB's Days Sales Outstanding or its related term are showing as below:

BOEUF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.33   Med: 61.49   Max: 74.34
Current: 58.45

During the past 12 years, Bonesupport Holding AB's highest Days Sales Outstanding was 74.34. The lowest was 55.33. And the median was 61.49.

BOEUF's Days Sales Outstanding is ranked better than
59.31% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 65.38 vs BOEUF: 58.45

Bonesupport Holding AB's Days Sales Outstanding declined from Jun. 2025 (61.79) to Jun. 2026 (55.54).


Bonesupport Holding AB  (OTCPK:BOEUF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Bonesupport Holding AB Days Sales Outstanding Related Terms


Bonesupport Holding AB Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB Days Sales Outstanding Chart

Bonesupport Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.00 57.59 57.61 62.91 62.65

Bonesupport Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.79 57.77 58.41 60.13 55.54

BOEUF vs ISRG, BDX, RMD: Days Sales Outstanding Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB Days Sales Outstanding vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's Days Sales Outstanding falls into.


BOEUF
79GF Score
Bonesupport Holding AB BOEUF
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bonesupport Holding AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2025 is calculated as

Days Sales Outstanding (A: Dec. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )*Days in Period
=( (17.733420820418 + 23.381785047945) / 2 ) / 119.7715964587*365
=20.557602934182 / 119.7715964587*365
=62.65

Bonesupport Holding AB's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding (Q: Jun. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2026 ) + Accounts Receivable (A: Jun. 2026 )) / count ) / Revenue (A: Jun. 2026 )*Days in Period
=( (23.334365568823 + 22.908717058529) / 2 ) / 37.986779255999*365 / 4
=23.121541313676 / 37.986779255999*365 / 4
=55.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 55.54 mean?
Bonesupport Holding AB (BOEUF) has a Days Sales Outstanding of 55.54 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Bonesupport Holding AB and its competitors. This is 10% below median its historical median of 61.49. Over the past decade, Bonesupport Holding AB's Days Sales Outstanding has ranged from 55.33 to 74.34. According to the industry distribution chart, Bonesupport Holding AB ranks #330 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 40.7%.
Is Bonesupport Holding AB's Days Sales Outstanding too high?
Bonesupport Holding AB's current Days Sales Outstanding of 55.54 is 10% below median its 10-year median of 61.49. Over the past 10 years, this metric has ranged from a low of 55.33 to a high of 74.34. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. Bonesupport Holding AB's value of 55.54 is 15.1% below this industry median. Based on the distribution chart, Bonesupport Holding AB ranks #330 out of 811 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Bonesupport Holding AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #330 out of 811 companies for Days Sales Outstanding. This puts Bonesupport Holding AB in the upper half of its industry. The industry median Days Sales Outstanding is 65.38. Bonesupport Holding AB's value of 55.54 is 15.1% below this benchmark. Historically, Bonesupport Holding AB's own Days Sales Outstanding has ranged from 55.33 to 74.34 over the past decade. While the company's 10-year median is 61.49 vs. the industry median of 65.38, Bonesupport Holding AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonesupport Holding AB's current Days Sales Outstanding of 55.54 is 15.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Bonesupport Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonesupport Holding AB's current Days Sales Outstanding is 55.54, which is 10% below median its own 10-year median of 61.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (BOEUF) is currently considered Significantly Undervalued. The stock's GF Value™ is $44.52, compared to a current price of $24.43 — trading 45.1% below its estimated fair value. The current Days Sales Outstanding is 55.54, which is 10% below median its 10-year median of 61.49 and 15.1% below the Medical Devices & Instruments industry median of 65.38. Bonesupport Holding AB's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Bonesupport Holding AB (BOEUF), the current Days Sales Outstanding is 55.54 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonesupport Holding AB (BOEUF) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of $24.43 is trading 45.1% below its estimated GF Value™ of $44.52. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for BOEUF:

  • Days Sales Outstanding: 55.54 (10% below median its 10-year median of 61.49)
  • GF Value™: $44.52 vs. price of $24.43 (45.1% below fair value)
  • GF Score™: 79/100 with 2 warning signs
  • Industry Position: 15.1% below the Medical Devices & Instruments median (#330 of 811)

No single metric tells the full story. See the BOEUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
79GF Score

Get the complete analysis for BOEUF

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.43
Price
$44.52
GF Value